BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19213072)

  • 21. Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-ĸB signaling, and synergizes with an ERK inhibitor.
    Yang F; Jove V; Chang S; Hedvat M; Liu L; Buettner R; Tian Y; Scuto A; Wen W; Yip ML; Van Meter T; Yen Y; Jove R
    Cancer Biol Ther; 2012 Apr; 13(6):349-57. PubMed ID: 22313636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nos2 inactivation promotes the development of medulloblastoma in Ptch1(+/-) mice by deregulation of Gap43-dependent granule cell precursor migration.
    Haag D; Zipper P; Westrich V; Karra D; Pfleger K; Toedt G; Blond F; Delhomme N; Hahn M; Reifenberger J; Reifenberger G; Lichter P
    PLoS Genet; 2012; 8(3):e1002572. PubMed ID: 22438824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo.
    Spiller SE; Logsdon NJ; Deckard LA; Sontheimer H
    BMC Cancer; 2011 Apr; 11():136. PubMed ID: 21492457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of suppressor-of-fused function promotes tumorigenesis.
    Lee Y; Kawagoe R; Sasai K; Li Y; Russell HR; Curran T; McKinnon PJ
    Oncogene; 2007 Sep; 26(44):6442-7. PubMed ID: 17452975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma.
    Vanner RJ; Remke M; Gallo M; Selvadurai HJ; Coutinho F; Lee L; Kushida M; Head R; Morrissy S; Zhu X; Aviv T; Voisin V; Clarke ID; Li Y; Mungall AJ; Moore RA; Ma Y; Jones SJ; Marra MA; Malkin D; Northcott PA; Kool M; Pfister SM; Bader G; Hochedlinger K; Korshunov A; Taylor MD; Dirks PB
    Cancer Cell; 2014 Jul; 26(1):33-47. PubMed ID: 24954133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linking DNA damage to medulloblastoma tumorigenesis in patched heterozygous knockout mice.
    Pazzaglia S; Tanori M; Mancuso M; Rebessi S; Leonardi S; Di Majo V; Covelli V; Atkinson MJ; Hahn H; Saran A
    Oncogene; 2006 Feb; 25(8):1165-73. PubMed ID: 16407852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kif3a is necessary for initiation and maintenance of medulloblastoma.
    Barakat MT; Humke EW; Scott MP
    Carcinogenesis; 2013 Jun; 34(6):1382-92. PubMed ID: 23389290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sonic Hedgehog signaling impairs ionizing radiation-induced checkpoint activation and induces genomic instability.
    Leonard JM; Ye H; Wetmore C; Karnitz LM
    J Cell Biol; 2008 Nov; 183(3):385-91. PubMed ID: 18955550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patched2 modulates tumorigenesis in patched1 heterozygous mice.
    Lee Y; Miller HL; Russell HR; Boyd K; Curran T; McKinnon PJ
    Cancer Res; 2006 Jul; 66(14):6964-71. PubMed ID: 16849540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zfx facilitates tumorigenesis caused by activation of the Hedgehog pathway.
    Palmer CJ; Galan-Caridad JM; Weisberg SP; Lei L; Esquilin JM; Croft GF; Wainwright B; Canoll P; Owens DM; Reizis B
    Cancer Res; 2014 Oct; 74(20):5914-24. PubMed ID: 25164012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma.
    Blotta S; Jakubikova J; Calimeri T; Roccaro AM; Amodio N; Azab AK; Foresta U; Mitsiades CS; Rossi M; Todoerti K; Molica S; Morabito F; Neri A; Tagliaferri P; Tassone P; Anderson KC; Munshi NC
    Blood; 2012 Dec; 120(25):5002-13. PubMed ID: 22821765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.
    Uziel T; Zindy F; Xie S; Lee Y; Forget A; Magdaleno S; Rehg JE; Calabrese C; Solecki D; Eberhart CG; Sherr SE; Plimmer S; Clifford SC; Hatten ME; McKinnon PJ; Gilbertson RJ; Curran T; Sherr CJ; Roussel MF
    Genes Dev; 2005 Nov; 19(22):2656-67. PubMed ID: 16260494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice.
    Zurawel RH; Allen C; Wechsler-Reya R; Scott MP; Raffel C
    Genes Chromosomes Cancer; 2000 May; 28(1):77-81. PubMed ID: 10738305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma.
    Vaillant C; Valdivieso P; Nuciforo S; Kool M; Schwarzentruber-Schauerte A; Méreau H; Cabuy E; Lobrinus JA; Pfister S; Zuniga A; Frank S; Zeller R
    PLoS One; 2015; 10(4):e0124870. PubMed ID: 25901736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response.
    Nowis D; McConnell EJ; Dierlam L; Palamarchuk A; Lass A; Wójcik C
    Int J Cancer; 2007 Jul; 121(2):431-41. PubMed ID: 17373661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma.
    Oliver TG; Read TA; Kessler JD; Mehmeti A; Wells JF; Huynh TT; Lin SM; Wechsler-Reya RJ
    Development; 2005 May; 132(10):2425-39. PubMed ID: 15843415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional loss of a noncanonical BCOR-PRC1.1 complex accelerates SHH-driven medulloblastoma formation.
    Kutscher LM; Okonechnikov K; Batora NV; Clark J; Silva PBG; Vouri M; van Rijn S; Sieber L; Statz B; Gearhart MD; Shiraishi R; Mack N; Orr BA; Korshunov A; Gudenas BL; Smith KS; Mercier AL; Ayrault O; Hoshino M; Kool M; von Hoff K; Graf N; Fleischhack G; Bardwell VJ; Pfister SM; Northcott PA; Kawauchi D
    Genes Dev; 2020 Sep; 34(17-18):1161-1176. PubMed ID: 32820036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of Pin1 Suppresses Hedgehog-Driven Medulloblastoma Tumorigenesis.
    Xu T; Zhang H; Park SS; Venneti S; Kuick R; Ha K; Michael LE; Santi M; Uchida C; Uchida T; Srinivasan A; Olson JM; Dlugosz AA; Camelo-Piragua S; Rual JF
    Neoplasia; 2017 Mar; 19(3):216-225. PubMed ID: 28167297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of noncompetitive proteasome inhibition on bortezomib resistance.
    Li X; Wood TE; Sprangers R; Jansen G; Franke NE; Mao X; Wang X; Zhang Y; Verbrugge SE; Adomat H; Li ZH; Trudel S; Chen C; Religa TL; Jamal N; Messner H; Cloos J; Rose DR; Navon A; Guns E; Batey RA; Kay LE; Schimmer AD
    J Natl Cancer Inst; 2010 Jul; 102(14):1069-82. PubMed ID: 20505154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma.
    Tanori M; Mancuso M; Pasquali E; Leonardi S; Rebessi S; Di Majo V; Guilly MN; Giangaspero F; Covelli V; Pazzaglia S; Saran A
    Carcinogenesis; 2008 Oct; 29(10):1911-9. PubMed ID: 18660545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.